Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sattler

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Plos One|October 8, 2011
Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cellsEllen Weisberg, Arghya Ray, Erik Nelson, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Blood|March 15, 2003
2-methoxyestradiol alters cell motility, migration, and adhesionMartin Sattler, Laura R Quinnan, Yuri B Pride, et al.
Blood|January 26, 2006
A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samplesMartin Sattler, Christoph Walz, Brian J Crowley, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Journal of Clinical Medicine|March 11, 2023
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision MedicineMartin Sattler, Isa Mambetsariev, Jeremy Fricke, et al.
Pharmaceutical Research|August 12, 2020
Repurposing of Kinase Inhibitors for Treatment of COVID-19Ellen Weisberg, Alexander Parent, Priscilla L Yang, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Plos One|October 8, 2011
Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cellsEllen Weisberg, Arghya Ray, Erik Nelson, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Blood|March 15, 2003
2-methoxyestradiol alters cell motility, migration, and adhesionMartin Sattler, Laura R Quinnan, Yuri B Pride, et al.
Blood|January 26, 2006
A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samplesMartin Sattler, Christoph Walz, Brian J Crowley, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Journal of Clinical Medicine|March 11, 2023
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision MedicineMartin Sattler, Isa Mambetsariev, Jeremy Fricke, et al.
Pharmaceutical Research|August 12, 2020
Repurposing of Kinase Inhibitors for Treatment of COVID-19Ellen Weisberg, Alexander Parent, Priscilla L Yang, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Pageof 13